Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-01

Clinical Trial Update: A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating doxazosin for nightmares, sleep disturbance, and non-nightmare PTSD symptoms; sponsored by the San Francisco VA Medical Cent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxazosin (doxazosin)

Snippet

Sponsor: San Francisco Veterans Affairs Medical Center | Conditions: Stress Disorders, Post-Traumatic | Phase 2 | Status: ACTIVE_NOT_RECRUITING